Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Cancer Research|April 1, 1986
Bladder cancer xenografts: a model of tumor cell heterogeneityP J Russell, D Raghavan, P Gregory, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancerJ F Bishop, R Kefford, D Raghavan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1987
Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancerJ F Bishop, D Raghavan, R Stuart-Harris, et al.
British Journal of Urology|November 1, 1993
Oral cyclophosphamide for the management of hormone-refractory prostate cancerD Raghavan, K Cox, B S Pearson, et al.
British Journal of Cancer|September 12, 2013
Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)S G Louie, B Ely, H-J Lenz, et al.
Cancer|October 15, 1982
Tumor classification and size in germ-cell testicular cancer: influence on the occurrence of metastasesD Raghavan, N J Vogelzang, G J Bosl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patientsJ P Stein, G Lieskovsky, R Cote, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 1992
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group studyP J Loehrer, L H Einhorn, P J Elson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Phase I and pharmacokinetic evaluation of floxuridine/leucovorin given on the Roswell Park weekly regimenP J Creaven, Y M Rustum, N J Petrelli, et al.
Journal of Surgical Oncology|August 1, 1983
Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapyR R Reddel, J F Thompson, D Raghavan, et al.
Pageof 17